BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19164257)

  • 1. Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients.
    Hwang YH; Son MJ; Yang J; Kim K; Chung W; Joo KW; Kim Y; Ahn C; Oh KH
    Perit Dial Int; 2009; 29(1):81-8. PubMed ID: 19164257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
    Pecoits-Filho R; Carvalho MJ; Stenvinkel P; Lindholm B; Heimbürger O
    Perit Dial Int; 2006; 26(1):53-63. PubMed ID: 16538876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
    Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
    Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysate cell-free mitochondrial DNA fragments as a marker of intraperitoneal inflammation and peritoneal solute transport rate in peritoneal dialysis.
    Xie X; Wang J; Xiang S; Chen Z; Zhang X; Chen J
    BMC Nephrol; 2019 Apr; 20(1):128. PubMed ID: 30975091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.
    Yang X; Zhang H; Hang Y; Yan H; Lin A; Huang J; Ni Z; Qian J; Fang W
    Am J Nephrol; 2014; 39(6):459-65. PubMed ID: 24854010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients.
    Cho Y; Johnson DW; Vesey DA; Hawley CM; Pascoe EM; Clarke M; Topley N;
    BMC Nephrol; 2014 Jan; 15():8. PubMed ID: 24410736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between interleukin-10 gene polymorphism -592 (A/C) and peritoneal transport in patients undergoing peritoneal dialysis.
    Lee YT; Tsai YC; Yang YK; Hsu KT; Liao SC; Wu CH; Cheng BC; Chen JB; Lee CH; Lee CT
    Nephrology (Carlton); 2011 Sep; 16(7):663-71. PubMed ID: 21777343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
    van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT
    Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients.
    Fijałkowski M; Safranow K; Lindholm B; Ciechanowski K; Muraszko AM; Dołęgowska B; Dołęgowska K; Golembiewska E
    Int Urol Nephrol; 2019 Sep; 51(9):1667-1673. PubMed ID: 31187425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate.
    Numata M; Nakayama M; Nimura S; Kawakami M; Lindholm B; Kawaguchi Y
    Perit Dial Int; 2003; 23(2):116-22. PubMed ID: 12713076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
    Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
    Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of residual renal function on peritoneal solute transport in dialysis patients.
    Matsuda A; Matsumura O; Ogawa T; Tayama Y; Motojima M; Maeda T; Noiri C; Kanouzawa K; Katou H; Hasegawa H; Mitarai T
    Am J Nephrol; 2010; 32(3):187-193. PubMed ID: 20639626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.
    Rodrigues AS; Almeida M; Fonseca I; Martins M; Carvalho MJ; Silva F; Correia C; Santos MJ; Cabrita A
    Nephrol Dial Transplant; 2006 Mar; 21(3):763-9. PubMed ID: 16332703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Peritoneal Glucose Exposure, Glucose Degradation Product Exposure, and Peritoneal Membrane Transport Characteristics in Peritoneal Dialysis Patients: Secondary Analysis of the
    Nataatmadja MS; Johnson DW; Pascoe EM; Darssan D; Hawley CM; Cho Y;
    Perit Dial Int; 2018; 38(5):349-355. PubMed ID: 30087174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the -374T/A receptor of advanced glycation end products gene polymorphism and peritoneal solute transport status at the initiation of peritoneal dialysis.
    Maruyama Y; Numata M; Nakayama M; Matsuo N; Nordfors L; Hosoya T; Lindholm B
    Ther Apher Dial; 2007 Aug; 11(4):301-5. PubMed ID: 17661837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal solute transport rate as an independent risk factor for total and cardiovascular mortality in a population of peritoneal dialysis patients.
    Janda K; Krzanowski M; Dumnicka P; Kuśnierz-Cabala B; Miarka P; Sułowicz W
    Adv Perit Dial; 2014; 30():15-20. PubMed ID: 25338416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of IL-6 and TIE2 gene polymorphisms in predicting the initial high transport status in patients with peritoneal dialysis: an observational study.
    Ding L; Shao X; Cao L; Fang W; Yan H; Huang J; Gu A; Yu Z; Qi C; Chang X; Ni Z
    BMJ Open; 2016 Oct; 6(10):e012967. PubMed ID: 27798027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.